180 related articles for article (PubMed ID: 31154721)
1. [Expression and prognosis effect of methylation-regulated SLIT3 and SPARCL1 genes in smoking-related lung adenocarcinoma].
Wang J; Yu XF; Ouyang N; Zhao SY; Guan XF; Yao HP; Chen R; Chen T; Li JX
Zhonghua Yi Xue Za Zhi; 2019 May; 99(20):1553-1557. PubMed ID: 31154721
[No Abstract] [Full Text] [Related]
2. Identification and validation of smoking-related genes in lung adenocarcinoma using an in vitro carcinogenesis model and bioinformatics analysis.
Wang J; Chen T; Yu X; OUYang N; Tan L; Jia B; Tong J; Li J
J Transl Med; 2020 Aug; 18(1):313. PubMed ID: 32795291
[TBL] [Abstract][Full Text] [Related]
3. Multi-platform analysis of methylation-regulated genes in human lung adenocarcinoma.
Wang J; Yu XF; OUYang N; Luo QL; Zhao SY; Guan XF; Chen T; Li JX
J Toxicol Environ Health A; 2019; 82(1):37-45. PubMed ID: 30626254
[TBL] [Abstract][Full Text] [Related]
4. Expression and Predictive Significance of FHL1 and SLIT3 in Surgically Resected Lung Adenocarcinoma.
Song J; Liang K; Wei T; Li L; Huang Z; Chen G; Mao N; Yang J
Comb Chem High Throughput Screen; 2023; 26(12):2226-2237. PubMed ID: 36752296
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
[TBL] [Abstract][Full Text] [Related]
6. Landscape of epigenetically regulated lncRNAs and DNA methylation in smokers with lung adenocarcinoma.
Jung J; Lee YJ; Kim CH; Ahn S
PLoS One; 2021; 16(3):e0247928. PubMed ID: 33684161
[TBL] [Abstract][Full Text] [Related]
7. Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation.
Deng H; Hang Q; Shen D; Zhang Y; Chen M
Cancer Cell Int; 2021 May; 21(1):259. PubMed ID: 33980221
[TBL] [Abstract][Full Text] [Related]
8. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
Chen D; Luo L; Liang C
PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide analysis of methylation CpG sites in gene promoters identified four pairs of CpGs-mRNAs associated with lung adenocarcinoma prognosis.
Pan X; Ji P; Deng X; Chen L; Wang W; Li Z
Gene; 2022 Feb; 810():146054. PubMed ID: 34737001
[TBL] [Abstract][Full Text] [Related]
10. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Liu X; Chen L; Zhang T
Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
[TBL] [Abstract][Full Text] [Related]
11. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.
Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J
J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of GSTM5 in lung adenocarcinoma is associated with DNA hypermethylation and poor prognosis.
Hao X; Zhang J; Chen G; Cao W; Chen H; Chen S
BMC Cancer; 2022 Jun; 22(1):685. PubMed ID: 35729618
[TBL] [Abstract][Full Text] [Related]
13. Elevated Expression of
Hu P; Huang Y; Gao Y; Yan H; Li X; Zhang J; Wang Y; Zhao Y
DNA Cell Biol; 2020 Apr; 39(4):522-532. PubMed ID: 32040344
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression.
Li H; Tong L; Tao H; Liu Z
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32031203
[TBL] [Abstract][Full Text] [Related]
15. Association of Tumor Suppressor Sparcl1 with Clinical Staging and Prognosis of NSCLC.
Zhou Y; Zhang Q
Ann Clin Lab Sci; 2021 Nov; 51(6):756-765. PubMed ID: 34921028
[TBL] [Abstract][Full Text] [Related]
16. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J
PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286
[TBL] [Abstract][Full Text] [Related]
17. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
Zhao Y; Gao Y; Xu X; Zhou J; Wang H
BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346
[TBL] [Abstract][Full Text] [Related]
18.
Yu J; Hou M; Pei T
DNA Cell Biol; 2020 May; 39(5):890-899. PubMed ID: 32282228
[TBL] [Abstract][Full Text] [Related]
19. Genome‑wide investigation of the clinical significance and prospective molecular mechanisms of kinesin family member genes in patients with lung adenocarcinoma.
Zhang L; Zhu G; Wang X; Liao X; Huang R; Huang C; Huang P; Zhang J; Wang P
Oncol Rep; 2019 Sep; 42(3):1017-1034. PubMed ID: 31322267
[TBL] [Abstract][Full Text] [Related]
20. GALNT2/14 overexpression correlate with prognosis and methylation: potential therapeutic targets for lung adenocarcinoma.
Yu Y; Wang Z; Zheng Q; Li J
Gene; 2021 Jul; 790():145689. PubMed ID: 33964375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]